About
Alex Seelenberger joined Aurus Asset Management in 2008 to lead the Venture Capital Life Science Division. Aurus BIOS, launched in 2010, has made 9 investments, with a focus on early stage development companies in biotechnology, specialty pharma, diagnostics and medical devices, agbio and industrial biotech. Previous to Aurus, Alex worked at Athelera LLC, a merger and acquisitions firm in New York, where he focused on M&As across several industries within Latin America. Additionally, he was a consultant for the Boston Consulting Group focusing primarily in pharmaceutical industry, financial services, and mining projects. Alex holds an MBA – Baker Scholar – from Harvard University and a Commercial Engineering degree from Universidad de Chile.
Position in the VCSift Database
- • 5 investors at Aurus are tracked.
- • 2,531 investors hold the Partner role in VCSift. Alex Seelenberger is one of them.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
Contact Information
Find more investors like Alex
Search Investors